What is the recommended dosage and treatment duration for progesterone (P4) tablets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Progesterone Tablet Dosage and Treatment Duration

For progesterone tablets, the recommended dosage is 200 mg orally once daily at bedtime for 12 days sequentially per 28-day cycle for prevention of endometrial hyperplasia, or 400 mg orally once daily at bedtime for 10 days for treatment of secondary amenorrhea. 1

Dosage Recommendations by Indication

Prevention of Endometrial Hyperplasia

  • Dosage: 200 mg oral progesterone daily at bedtime
  • Duration: 12 days sequentially per 28-day cycle
  • Patient population: Postmenopausal women with a uterus who are receiving daily conjugated estrogens 1
  • Take with a glass of water while standing if swallowing difficulties occur 1

Treatment of Secondary Amenorrhea

  • Dosage: 400 mg oral progesterone daily at bedtime
  • Duration: 10 days
  • Administration: Take with a glass of water while standing if swallowing difficulties occur 1

Preterm Birth Prevention

For women with singleton pregnancies and prior spontaneous preterm birth (SPTB), the evidence supports:

  • 17-alpha-hydroxyprogesterone caproate (17P) is preferred: 250 mg IM weekly from 16-20 weeks until 36 weeks 2
  • Vaginal progesterone is an alternative when 17P is unavailable 2
  • For women with short cervical length (≤20 mm) at 24 weeks but no prior preterm birth: vaginal progesterone 90-mg gel or 200-mg suppository daily until 36 weeks 2

Important note: There is insufficient evidence supporting progesterone use for multiple gestations, preterm labor, or preterm premature rupture of membranes 2

Alternative Regimens for Postmenopausal Women

For postmenopausal women requiring hormone replacement therapy:

  • For women wishing regular monthly bleeding: 300 mg/day (taken at bedtime) for 10 days a month 3
  • For women willing to remain amenorrheic: 200 mg for 14 days a month or 100 mg for 25 days a month 3

Considerations for Administration

  • Bedtime administration is recommended to minimize drowsiness, which is a mild and transient side effect 3
  • Oral micronized progesterone has been recommended as the first choice for opposing estrogen therapy in nonhysterectomized postmenopausal women 3
  • For women with difficulty swallowing, progesterone capsules should be taken with a glass of water while standing 1

Monitoring

  • Initial evaluation should be done at 3-6 months after starting therapy
  • Annual clinical review thereafter, monitoring for:
    • Symptom control
    • Compliance
    • Blood pressure
    • Weight

Potential Side Effects and Contraindications

  • Common side effect: Mild and transient drowsiness (minimized by bedtime administration) 3
  • Contraindications include:
    • History of breast cancer
    • Active thromboembolic disorders
    • History of arterial thrombotic disease
    • Undiagnosed vaginal bleeding
    • Liver problems

Clinical Pearls

  • Oral micronized progesterone has fewer metabolic and vascular side effects compared to synthetic progestins 3
  • Progesterone must be added to estrogen therapy for at least 10-14 days per month to prevent endometrial hyperplasia in women with an intact uterus 3
  • Dose-dependent effects have been observed, with higher doses (300 mg daily) achieving responses within the physiological range 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral micronized progesterone.

Clinical therapeutics, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.